platelet derived growth factor-D antagonist (Seattle Life Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameplatelet derived growth factor-D antagonist (Seattle Life Sciences)
Drug Alias NamePDGF-D antagonist (Seattle Life Sciences)PDGF-D antagonist (ZymoGenetics)platelet derived growth factor-D antagonist (ZymoGenetics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor D antagonists
TargetsPlatelet-derived growth factor D
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A